These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 2554875)

  • 41. Effect of milrinone on ethanol and halothane induced cardiodepression.
    Neira S; Penna M
    Acta Physiol Pharmacol Latinoam; 1988; 38(2):193-211. PubMed ID: 2847492
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiovascular pharmacology of the vasodilator-cardiotonic agent, 349U85.
    Steffen RP; Wastila WB
    J Cardiovasc Pharmacol; 1992 Oct; 20(4):579-89. PubMed ID: 1280714
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structure-activity relationships of milrinone analogues determined in vitro in a rabbit heart membrane Ca(2+)-ATPase model.
    Cody V; Wojtczak A; Davis FB; Davis PJ; Blas SD
    J Med Chem; 1995 May; 38(11):1990-7. PubMed ID: 7783130
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The positive inotropic response to milrinone in isolated human and guinea pig myocardium.
    Brown L; Näbauer M; Erdmann E
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct; 334(2):196-201. PubMed ID: 3024033
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of acidosis on cardiotonic effects of milrinone.
    Tanaka M; Ishikawa T; Nishikawa T; Goto K; Sato S
    Anesthesiology; 1998 Mar; 88(3):725-34. PubMed ID: 9523817
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mechanism of the positive inotropic effect of milrinone in cultured embryonic chick ventricular cells.
    Olson EM; Kim D; Smith TW; Marsh JD
    J Mol Cell Cardiol; 1987 Jan; 19(1):95-104. PubMed ID: 2435920
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reduction of 4-epiadriamycin cardiotoxicity by milrinone, a new cardiotonic agent.
    Bossa R; Aresca P; Galatulas I; Ninci M
    Anticancer Res; 1989; 9(3):605-8. PubMed ID: 2764506
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of a novel inotropic agent, BAY y 5959, in conscious dogs: comparison with dobutamine and milrinone.
    Sato N; Uechi M; Asai K; Patrick T; Kudej RK; Vatner SF
    Am J Physiol; 1997 Feb; 272(2 Pt 2):H753-9. PubMed ID: 9124435
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of milrinone (Win 47203) on the in vitro electropharmacological properties of mammalian cardiac tissue.
    Canniff PC; Farah AE; Sperelakis N; Wahler GM
    J Cardiovasc Pharmacol; 1985; 7(5):813-21. PubMed ID: 2413286
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modulation of the contractility of guinea pig papillary muscle by the activation of ATP-sensitive K+ channels.
    Kocić I
    Eur J Pharmacol; 1996 Apr; 301(1-3):115-9. PubMed ID: 8773454
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Positive inotropic and chronotropic effects of toborinone and its electrophysiological properties in the isolated hearts of rabbits and guinea-pigs.
    Takase H; Orito K; Mori T; Fujiki H; Sekiguchi K; Tominaga M; Iijima T
    Arzneimittelforschung; 1996 Jun; 46(6):579-86. PubMed ID: 8767347
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Myocardial actions of milrinone: characterization of its mechanism of action.
    Rapundalo ST; Grupp I; Grupp G; Abdul Matlib M; Solaro RJ; Schwartz A
    Circulation; 1986 Mar; 73(3 Pt 2):III134-44. PubMed ID: 2417746
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 1st communication: studies on isolated guinea pig cardiac muscles.
    Ogawa T; Ohhara H; Tsunoda H; Kuroki J; Shoji T
    Arzneimittelforschung; 1989 Jan; 39(1):33-7. PubMed ID: 2566308
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The search for a digitalis substitute II milrinone (Win 47203). Its action on the heart-lung preparation of the dog.
    Pastelin G; Mendez R; Kabela E; Farah A
    Life Sci; 1983 Oct; 33(18):1787-96. PubMed ID: 6645777
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Selective inhibition of cyclic AMP phosphodiesterase from various human tissues by milrinone, a potent cardiac bipyridine.
    Ito M; Tanaka T; Saitoh M; Masuoka H; Nakano T; Hidaka H
    Biochem Pharmacol; 1988 May; 37(10):2041-4. PubMed ID: 2837222
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of temperature on the positive inotropic effect of levosimendan, dobutamine and milrinone.
    Rieg AD; Schroth SC; Grottke O; Hein M; Ackermann D; Rossaint R; Schälte G
    Eur J Anaesthesiol; 2009 Nov; 26(11):946-53. PubMed ID: 19687740
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New milrinone analogues: in vitro study of structure-activity relationships for positive inotropic effect, antagonism towards endogenous adenosine, and inhibition of cardiac type III phosphodiesterase.
    Floreani M; Fossa P; Gessi S; Mosti L; Borea PA; Dorigo P
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Feb; 367(2):109-18. PubMed ID: 12595951
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New inotropic agents: milrinone analogs.
    Dorigo P; Fraccarollo D; Gaion RM; Santostasi G; Borea PA; Floreani M; Mosti L; Maragno I
    Gen Pharmacol; 1997 May; 28(5):781-8. PubMed ID: 9184820
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selective inhibition of cAMP phosphodiesterase III activity by the cardiotonic agent saterinone in guinea pig myocardium.
    Brunkhorst D; von der Leyen H; Meyer W; Schmidt-Schumacher C; Scholz H
    Arzneimittelforschung; 1988 Sep; 38(9):1293-8. PubMed ID: 2852013
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MCI-154, a cardiac Ca2+ sensitizer, reverses the depression in maximal Ca2+-activated force by inorganic phosphate and acidic pH in skinned fiber of guinea pig heart.
    Kitada Y
    Cardiovasc Drugs Ther; 1997 Nov; 11(5):611-8. PubMed ID: 9493698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.